Currently Viewing:
Currently Reading
Out-of-Pocket Costs for Insulin Are a Problem. Litigants in Case Disagree on Who Is at Fault
March 22, 2018 – Mary Caffrey
Study Finds Canagliflozin Can Reduce A1C at Lower Cost Than GLP-1 Drugs
March 22, 2018 – Mary Caffrey
What We're Reading: Drug Pricing Measures; Gun Violence Research; Postmarketing Safety Reporting
March 22, 2018 – AJMC staff
House Sends Right-to-Try Bill to Senate After 267-149 Vote
March 22, 2018 – Allison Inserro
AIDS Researcher Dr Robert Redfield Named New CDC Director
March 22, 2018 – Laura Joszt
HIV Incidence, Prevalence Remain Highest in Men Who Have Sex With Men
March 21, 2018 – Jaime Rosenberg
Seven ACOs Exit Next Generation Model, Blaming CMS for "Unilateral" Changes
March 21, 2018 – Allison Inserro
Panel Discusses Training Healthcare Providers to Better Care for the LGBTQ Community
March 21, 2018 – Laura Joszt
Patients Worldwide Are Treated With Inappropriate Care for Low Back Pain, Journal Says
March 21, 2018 – Allison Inserro

Identifying the Most Prevalent and Costly Chronic Conditions in Medicaid

Laura Joszt
High prevalence of chronic conditions has been a key driver of healthcare costs in the United States, and Medicaid beneficiaries tend to have higher rates of chronic diseases than people not on Medicaid.
High prevalence of chronic conditions has been a key driver of healthcare costs in the United States, and Medicaid beneficiaries tend to have higher rates of chronic diseases than people not on Medicaid.

A new review published in American Journal of Preventive Medicine examined studies published between 2000 and 2016 to estimate the prevalence and cost of noncommunicable chronic diseases in Medicaid.

“As the Medicaid population continues to change, it is increasingly important to understand the major health burdens this population faces and the associated medical costs, which is important for informing future program design and developing health promotion programs to contain or reduce the public health burden and healthcare costs,” the authors explained.

The review looked at adults between the ages of 18 and 64 years and, based on the 29 studies selected, reported the following prevalence estimates:
  • 8.8% to 11.8% for heart disease
  • 17.2% to 27.4% for hypertension
  • 16.8% to 23.2% for hyperlipidemia
  • 7.5% to 12.7% for diabetes
  • 9.5% for cancer
  • 7.8% to 19.3% for asthma
  • 5% to 22.3% for depression
  • 55.7% to 62.1% for 1 or more chronic conditions
The review presented the total cost per patient with disease and the disease-related cost per patient with disease separately. For total cost per patient, heart failure/congestive heart failure ($29,271 to $51,937) and cancer ($29,384 to $46,194) were the most expensive. However, in the disease-related cost category, congenital heart disease ($5835), heart failure/congestive heart failure ($7031), and chronic obstructive pulmonary disease (COPD) ($3968 to $6491) were the most expensive based on the studies reviewed.

In general, Medicaid beneficiaries have a high prevalence of heart diseases. Hypertension, hyperlipidemia, heart disease, and diabetes were common comorbidities. The review also found that patients with COPD had high rates of hypertension and diabetes.

The authors did acknowledge some limitations, such as many studies using state-level data, which is important since states’ Medicaid populations can vary. In addition, the use of claims data in many of the studies in the review might undercount the number of patients with certain chronic conditions. Despite the limitations, the review confirms the high prevalence of noncommunicable chronic diseases among Medicaid beneficiaries.

“The specific prevalence and cost estimates highlighted here could be used to inform the evaluation of interventions for effectively managing chronic diseases and controlling costs in this vulnerable population and for informing future designs of the Medicaid program,” the authors concluded.

Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!